Embree Financial Group’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Sell
3,219
-986
-23% -$179K 0.05% 173
2026
Q1
$619K Buy
4,205
+1,142
+37% +$186K 0.07% 146
2025
Q4
$597K Buy
3,063
+162
+6% +$38.6K 0.07% 142
2025
Q3
$816K Buy
2,901
+74
+3% +$18.8K 0.11% 116
2025
Q2
$618K Sell
2,827
-43
-1% -$6.94K 0.09% 128
2025
Q1
$401K Buy
2,870
+431
+18% +$70.2K 0.07% 139
2024
Q4
$406K Sell
2,439
-49
-2% -$8.7K 0.07% 132
2024
Q3
$424K Sell
2,488
-75
-3% -$10.9K 0.08% 126
2024
Q2
$362K Sell
2,563
-199
-7% -$24.7K 0.07% 134
2024
Q1
$347K Buy
2,762
+287
+12% +$32.8K 0.07% 139
2023
Q4
$261K Buy
+2,475
New +$270K 0.05% 152

Other funds holding ORCL

Embree Financial Group's ORCL Position: Q2 2026 in Review

Embree Financial Group reduced its Oracle (ORCL) stake by 23% in Q2 2026, selling an estimated $179K and leaving 3,219 shares worth $472K. The position accounts for 0.05% of the portfolio, ranked #173.

Embree Financial Group first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $816K in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Embree Financial Group held 3,219 shares of Oracle worth $472K as of Q2 2026.
  • Embree Financial Group sold 986 Oracle shares in Q2 2026, an estimated $179K.
  • Oracle made up 0.05% of Embree Financial Group's portfolio in Q2 2026, its #173 holding.
  • Embree Financial Group first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • Embree Financial Group's Oracle position peaked at $816K in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.